Mylan launch first Nislodipine generic in US market
Mylan got final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Nisoldipine Extended-release (ER) Tablets, 20 mg, 30 mg and 40 mg. Nisoldipine ER Tablets, indicated for the treatment of hypertension, are the generic version of Sciele Pharma's Sular(R) ER Tablets.
Ranbaxy launched authorized generic of Omeprazole
Ranbaxy announced that under an agreement with AstraZeneca Pharma it has launched an authorized generic of Omeprazole 40 mg Capsules in the U.S. market. Omeprazole 40 mg is indicated for the treatment of acid-related disease, including gastric ulcer and Zollinger-Ellison syndrome. Prilosec(R) 40 mg had sales in the U.S. market of $205 million.
Tuesday 29 July, 2008
Mylan launch first Nislodipine generic in US market, Ranbaxy launched authorized generic of Omeprazole
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment